Drug-induced nail disorders - Incidence, management and prognosis

被引:45
|
作者
Piraccini, BM [1 ]
Tosti, A [1 ]
机构
[1] Univ Bologna, Dept Dermatol, I-40136 Bologna, Italy
关键词
D O I
10.2165/00002018-199921030-00004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A large number of drugs of different classes, ranging from antibacterials to chemotherapeutic agents to psoralens, can be responsible for the development of nail changes. Drug-induced nail changes usually involve several or all 20 nails and appear in temporal correlation with drug intake. Some nail changes are asymptomatic and only cause cosmetic problems, while others cause pain and discomfort and impair manual activities or deambulation. Drug-induced nail abnormalities are usually transitory and disappear with drug withdrawal, but sometimes persist in time. The pathogenesis of the nail changes is usually a toxic effect of the drug on the different nail constituents. but other mechanisms can be involved. Drugs that are well known to produce nail abnormalities include cancer chemotherapeutic agents, psoralens, retinoids, tetracyclines, antimalarials and zidovudine. Arsenic poisoning is also always associated with nail changes that have medico-legal importance. Some drugs taken during pregnancy may impair nail development of the fetus, and nail hypoplasia or other nail dystrophies will be evident in the newborn.
引用
下载
收藏
页码:187 / 201
页数:15
相关论文
共 50 条
  • [1] Drug-Induced Nail DisordersIncidence, Management and Prognosis
    Bianca Maria Piraccini
    Antonella Tosti
    Drug Safety, 1999, 21 : 187 - 201
  • [2] DRUG-INDUCED NAIL DISORDERS (IATROGENIC NAIL DISEASES)
    KREBS, A
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1981, 70 (44): : 1951 - 1959
  • [3] Drug-induced rheumatic disorders -: Incidence, prevention and management
    Vergne, P
    Bertin, P
    Bonnet, C
    Scotto, C
    Trèves, R
    DRUG SAFETY, 2000, 23 (04) : 279 - 293
  • [4] Drug-induced respiratory disorders: Incidence, prevention and management
    Ben-Noun, L
    DRUG SAFETY, 2000, 23 (02) : 143 - 164
  • [5] DRUG-INDUCED HEPATIC DISORDERS - INCIDENCE, MANAGEMENT AND AVOIDANCE
    DOSSING, M
    SONNE, J
    DRUG SAFETY, 1993, 9 (06) : 441 - 449
  • [6] Drug-Induced Skin, Nail and Hair Disorders
    Laurence Valeyrie-Allanore
    Bruno Sassolas
    Jean-Claude Roujeau
    Drug Safety, 2007, 30 : 1011 - 1030
  • [7] Drug-induced skin, nail and hair disorders
    Valeyrie-Allanore, Laurence
    Sassolas, Bruno
    Roujeau, Jean-Claude
    DRUG SAFETY, 2007, 30 (11) : 1011 - 1030
  • [8] Drug-induced nail disorders: Prevention is best
    不详
    Drugs & Therapy Perspectives, 2000, 16 (1) : 13 - 16
  • [9] DRUG-INDUCED DISORDERS OF BONE METABOLISM - INCIDENCE, MANAGEMENT AND AVOIDANCE
    JONES, G
    SAMBROOK, PN
    DRUG SAFETY, 1994, 10 (06) : 480 - 489
  • [10] Drug-induced bladder and urinary disorders - Incidence, prevention and management
    Drake, MJ
    Nixon, PM
    Crew, JP
    DRUG SAFETY, 1998, 19 (01) : 45 - 55